| |
|
|
- MEK Inhibitor Selumetinib
- Selumetinib, also known as AZD6244 or ARRY-142886, is a selective, non-ATP-competitive oral MEK1/2 inhibitor, which is used in the treatment of neurofibromatosis type I (NF-1) for children two years of age or older.
-
MedChemHub
[Verified]
|
|
Negotiable
|
